Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

Published:2019-10-02 Issue:1 Volume:27 Page:28-35
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Laursen Tea Lund¹^ORCID,Siggaard Cecilie Brøckner¹,Kazankov Konstantin¹,Sandahl Thomas Damgaard¹,Møller Holger Jon²,Tarp Britta³,Kristensen Lena Hagelskjær⁴,Laursen Alex Lund⁵,Leutscher Peter⁶⁷,Grønbæk Henning¹

Affiliation:

1. Department of Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark

2. Department of Clinical Biochemistry Aarhus University Hospital Aarhus Denmark

3. Diagnostic Centre Silkeborg Regional Hospital Silkeborg Denmark

4. Department of Medicine Viborg Regional Hospital Viborg Denmark

5. Department of Infectious Diseases Aarhus University Hospital Aarhus Denmark

6. Centre for Clinical Research North Denmark Regional Hospital Hjørring Denmark

7. Department of Clinical Medicine Aalborg University Aalborg Denmark

Funder

Strategic Research Council

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13204

Reference44 articles.

1. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

2. All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

3. All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database

4. Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

5. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors;Scientific Reports;2024-07-16

2. Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?;Clinics;2024-01

3. Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity;International Journal of Molecular Sciences;2023-12-23

4. Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation;Expert Opinion on Investigational Drugs;2023-11-28

5. Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs);Egyptian Liver Journal;2023-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3